- Home
- BNTC vs PMVP Comparison
BNTC vs PMVP Comparison
Compare BNTC & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- PMVP
- Stock Information
- Founded
- BNTC 1995
- PMVP 2013
- Country
- BNTC United States
- PMVP United States
- Employees
- BNTC N/A
- PMVP N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- BNTC Health Care
- PMVP Health Care
- Exchange
- BNTC Nasdaq
- PMVP Nasdaq
- Market Cap
- BNTC 88.1M
- PMVP 85.5M
- IPO Year
- BNTC N/A
- PMVP 2020
- Fundamental
- Price
- BNTC $10.68
- PMVP $1.61
- Analyst Decision
- BNTC Strong Buy
- PMVP Strong Buy
- Analyst Count
- BNTC 5
- PMVP 4
- Target Price
- BNTC $22.60
- PMVP $5.75
- AVG Volume (30 Days)
- BNTC 33.8K
- PMVP 209.2K
- Earning Date
- BNTC 11-14-2024
- PMVP 11-07-2024
- Dividend Yield
- BNTC N/A
- PMVP N/A
- EPS Growth
- BNTC N/A
- PMVP N/A
- EPS
- BNTC N/A
- PMVP N/A
- Revenue
- BNTC N/A
- PMVP N/A
- Revenue This Year
- BNTC N/A
- PMVP N/A
- Revenue Next Year
- BNTC N/A
- PMVP N/A
- P/E Ratio
- BNTC N/A
- PMVP N/A
- Revenue Growth
- BNTC N/A
- PMVP N/A
- 52 Week Low
- BNTC $2.69
- PMVP $1.40
- 52 Week High
- BNTC $12.89
- PMVP $3.47
- Technical
- Relative Strength Index (RSI)
- BNTC 53.25
- PMVP 47.86
- Support Level
- BNTC $10.25
- PMVP $1.59
- Resistance Level
- BNTC $10.89
- PMVP $1.82
- Average True Range (ATR)
- BNTC 0.43
- PMVP 0.07
- MACD
- BNTC -0.07
- PMVP -0.01
- Stochastic Oscillator
- BNTC 69.39
- PMVP 8.70
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.